As of December 31,

2021

2022

ASSETS

Cash and cash equivalents

—

171

Other receivables, net

—

9,830

Amounts due from related parties

—

3,726

Investment in subsidiaries and consolidated VIEs

$

29,662

$

27,964

Total assets

29,662

41,691

LIABILITIES AND SHAREHOLDERS’ EQUITY

Accrued expenses and other current liabilities

—

4,257

Amounts due to related parties

—

200

Convertible note

—

4,305

Other liability

—

1,614

Total liabilities

—

10,376

Shareholders’ equity

Ordinary Shares (par value of $0.00005 per shares; 1,000,000,000 shares authorized, 163,129,655 and 238,368,861 shares issued as of December 31, 2021 and 2022, respectively. 163,129,655 and 228,250,210 shares issued and outstanding as of December 31, 2021 and 2022, respectively)

8

11

Series D convertible preferred shares (par value of $0.0001, 6,000 shares authorized as of December 31, 2021 and 2022, respectively. 6,000 shares issued and outstanding as of December 31, 2021 and 2022 respectively)

1

3

Additional paid-in capital

227,310

312,831

Accumulated deficit

(198,294)

(283,000)

Accumulated other comprehensive income (loss)

637

1,470

Total shareholders’ equity

29,662

31,315

Total liabilities and shareholders’ equity

$

29,662

$

41,691